Rhode Island Hospital researchers find drug to weaken ‘superbug’ cells

A DRUG that may make a strain of “superbug” more vulnerable to treatment by antibiotics has been identified by an international research effort led by a team at Rhode Island Hospital. Above, Dr. Eleftherios Mylonakis, chief of infectious diseases at Rhode Island Hospital and The Miriam Hospital. / COURTESY LIFESPAN
A DRUG that may make a strain of “superbug” more vulnerable to treatment by antibiotics has been identified by an international research effort led by a team at Rhode Island Hospital. Above, Dr. Eleftherios Mylonakis, chief of infectious diseases at Rhode Island Hospital and The Miriam Hospital. / COURTESY LIFESPAN
PROVIDENCE – A drug that may make a strain of “superbug” more vulnerable to treatment by antibiotics has been identified by an international research effort led by a team at Rhode Island Hospital. Researchers found that the drug bithionol, which has been used to treat tapeworms in horses and liver parasites in animals and humans,…

Want More?

Subscribe or register with Providence Business News to keep reading.

REGISTER
for 2 more stories

Subscribe now for $1 for 4 weeks
Already a Subscriber? Login now

Purchase NowWant to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.

- Advertisement -